EQS-News: Marinomed Biotech AG: M8 Pharmaceuticals obtains market authorization for Carragelose nasal spray in Mexico
EQS-News: Marinomed Biotech AG / Key word(s): Regulatory Approval
Marinomed Biotech AG: M8 Pharmaceuticals obtains market authorization for Carragelose nasal spray in Mexico
27.07.2023 / 07:45 CET/CEST
The issuer is solely responsible for the content of this announcement.
═══════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════
Marinomed Biotech AG: M8 Pharmaceuticals obtains market authorization for Carragelose!-->…